In commercial poultry drinking water systems, Qianjin Powder Veterinary Grade API is dispersed into a water-soluble carrier to enable continuous medication through nipple drinkers without filter clogging. The carrier matrix consists of 2.5% w/w to 8.0% w/w API, diluted in dextrose monohydrate and sodium citrate, with final in-use concentration typically 0.5 g/L to 2.0 g/L depending on flock body weight and water intake. Compliance is governed by EU Regulation (EU) 2019/6 Annex II for veterinary medicinal product authorization and 21 CFR 211.165 for finished pharmaceutical testing. Dry blending is performed in a 500 L U-trough ribbon blender with a 15 rpm agitator and a high-speed chopper run for 6 min during the final third of the mixing cycle; blend uniformity measured by HPLC marker assay remains below 5.0% RSD after 18 min. The powder is sieved through an 840 µm vibratory screen before packaging into foil-lined heat-sealed sachets of 100 g, 500 g, and 1 kg. The terminal product is a water-soluble powder for oral solution intended for dissolution in drinking water tanks or proportioner units.

What Filtration Membrane and pH Range Prevent Precipitation in Injectable Solutions?

Injectable solutions containing Qianjin Powder Veterinary Grade API require a buffered aqueous-organic vehicle to maintain solubility during terminal sterilization and storage. The solution is compounded at 10 mg/mL to 50 mg/mL expressed as the dried API, with 0.9% w/v sodium chloride and 20% v/v propylene glycol; pH is adjusted to 5.5–6.5 using 10 mM citrate buffer. Below pH 4.8, precipitation of phenolic marker constituents increases filter resistance and reduces product assay; above pH 7.2, oxidative discoloration has been documented in pilot batches. Compliance is evaluated under Ph. Eur. 2.6.1 for sterility, Ph. Eur. 2.6.14 for bacterial endotoxins, and VICH GL18(R2) for residual solvents. Terminal sterilization is performed by autoclaving at 121°C for 15 min if the API lot displays thermostability above 120°C in differential scanning calorimetry; otherwise, aseptic filtration through a 0.22 µm PVDF membrane is used before filling under ISO 14644-1 Class 5 laminar airflow. Filling lines employ rotary piston pumps with ceramic cylinders operating at 20 strokes/min to avoid cavitation; in-process weight checks are performed every 30 min against a ±1.5% limit. The terminal product is a 100 mL multi-dose vial for intramuscular or subcutaneous injection in cattle and swine.

Feed Premix Homogeneity, Particle Size Conflict, and Carryover Control

Qianjin Powder Veterinary Grade API is incorporated into medicated feed premixes where homogeneous distribution at final feed inclusion rates below 1 kg/tonne is the controlling process risk. The active premix is manufactured at 50 g/kg to 200 g/kg API in a carrier of ground wheat middlings or calcium carbonate, using a 1000 L double-ribbon mixer. Stepwise geometric dilution is required when the API fraction is less than 5% of the total batch. Compliance is anchored to EU Regulation (EU) 2019/4 for medicated feed, 21 CFR 225.10 and 225.120 for current good manufacturing practices in medicated feed mills, and Codex CAC/RCP 54-2004 for animal feed hygiene. The downstream process includes hammer milling to a D90 of 250 µm, but if the API particle size is below 50 µm, electrostatic agglomeration during transfer increases carryover and reduces blend uniformity; in such cases, dry granulation is inserted before final mixing. Batch-to-batch variance in carrier moisture above 12% has been associated with bridging in discharge ports and should be controlled with pre-dryers set at 40°C for 2 h. The terminal product is a medicated premix packed in multi-wall paper bags with an inner polyethylene liner, intended for mixing into complete feed at feed mills.

For oral granule production destined for piglet top-dressing or oral syringe reconstitution, Qianjin Powder Veterinary Grade API is agglomerated using top-spray fluid-bed granulation when its bulk flowability is insufficient for direct packaging. The formulation contains 15% w/w API, 70% w/w lactose monohydrate, 10% w/w microcrystalline cellulose, and 5% w/w povidone K30 as binder. Granulation is executed in a top-spray fluid-bed dryer with inlet air temperature of 50°C, spray rate of 15 g/min/kg of batch, and inlet air dew point at 8°C. Final granule size is controlled to 180–500 µm; particles below 150 µm are recycled into the next batch at a maximum ratio of 20% to avoid overwetting. Loss on drying after granulation must remain below 3.0%, monitored by halogen moisture analyzer. Compliance is assessed under Ph. Eur. 2.9.36 for powder flow and 21 CFR 211.110 for in-process sampling. The terminal product is an oral granule in sachets of 200 g, administered by top-dressing on feed or after reconstitution with water as a drench. Published data for the specific binder interactions of Qianjin Powder in top-spray fluid-bed systems is limited; pilot trials with the exact lactose source are advised.

When Direct Compression of Small Animal Tablets Is Preferable to Wet Granulation

Small animal tablet production using Qianjin Powder Veterinary Grade API frequently opts for direct compression when the API particle size distribution is within 75–150 µm and the bulk density of the blend exceeds 0.55 g/cm³. The tablet core formulation includes 20% w/w API, 65% w/w microcrystalline cellulose, 10% w/w crospovidone, 1% w/w magnesium stearate, and 4% w/w colloidal silicon dioxide. Direct compression is performed on a rotary tablet press equipped with 10 mm round flat-faced tooling; compaction force is set at 30 kN, turret speed at 60 rpm, and target hardness at 70–100 N. If room relative humidity exceeds 60%, the API must be pre-dried at 40°C for 4 h before lubrication because absorbed moisture causes picking on the punch faces. Disintegration time is tested according to USP <2040> and should not exceed 15 min in 37°C water. Compliance also includes USP <2091> for weight variation and 21 CFR 211.165 for release testing. The terminal product is a scored tablet in aluminum-aluminum blister packs for canine and feline dosing.

Because capsule filling requires consistent bulk density, the Qianjin Powder Veterinary Grade API is first dry-granulated through slugging when tapped density exceeds 0.45 g/cm³ or when the flow rate through a 15 mm funnel is slower than 10 g/s. The capsule formulation targets 250 mg API per capsule with a total fill weight of 400 mg; the remaining fill consists of 60% lactose monohydrate, 30% microcrystalline cellulose, and 0.5% colloidal silica. The process uses a slugging press at 10 kN and an oscillating granulator fitted with a 1.0 mm screen to produce free-flowing granules. An automatic capsule filling machine operates at 70,000 capsules/h with in-process fill weight checks every 15 min; rejection limits are set at ±5% of target fill. Dissolution testing follows USP <711> Apparatus II at 50 rpm in 900 mL of pH 6.8 phosphate buffer. Compliance with USP <2091> for mass uniformity and Ph. Eur. 2.9.5 for content uniformity is required. The capsule shells are hard gelatin or HPMC, and the terminal product is packed in HDPE bottles with induction-sealed closures and desiccant to limit moisture migration.

In oral drench solutions for ruminants, Qianjin Powder Veterinary Grade API is dissolved or dispersed in a non-aqueous vehicle to prevent hydrolysis during long-term storage. The solution is formulated to deliver 25 mg/kg body weight in a single drench dose, with an API concentration of 50 mg/mL in a vehicle of propylene glycol and water in a 1:1 ratio. Compliance includes Ph. Eur. 2.2.3 for pH measurement, USP <795> for compounding nonsterile preparations, and 21 CFR 211.165 for release testing. The manufacturing process uses a jacketed stainless steel vessel with a high-shear disperser at 3,000 rpm for 15 min to break agglomerates, followed by filtration through a 100 µm inline strainer before filling into 1 L HDPE dosing bottles. Aqueous formulations above 40% water without antioxidant are not recommended because oxidative degradation can occur within 90 days at 30°C. The terminal product is an oral solution for drenching cattle, sheep, and goats.